May 20, 2020 / 9:02 PM / 11 days ago

BRIEF-China Biologic Comments On The Xinjiang Deyuan And Shuanglin Transaction

May 20 (Reuters) - China Biologic Products Holdings Inc :

* CHINA BIOLOGIC COMMENTS ON THE XINJIANG DEYUAN AND SHUANGLIN TRANSACTION

* CHINA BIOLOGIC - XINJIANG DEYUAN BIOENGINEERING HAS MATERIALLY BREACHED STRATEGIC COOPERATION WITH CO

* CHINA BIOLOGIC - XINJIANG DEYUAN BIOENGINEERING BREACHED COOPERATION BY ENTERING INTO PLASMA SUPPLY ARRANGEMENTS WITH SOUTHERN SHUANGLIN BIO-PHARMACY

* CHINA BIOLOGIC - WILL TAKE NECESSARY MEASURES TO PROTECT ITS RIGHTS & RECOUP POTENTIAL LOSSES DUE TO XINJIANG DEYUAN’S BREACH OF COOPERATION AGREEMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below